Home/Topics/Locations & Geopolitics/Washington, D.C.

📍Location Dossier

Washington, D.C.

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

14 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Big Tech, Cloud & Semiconductors 11 Nov 2026, 08:00 AM IST

FDA Flags Rare Vision Risk in GLP-1 Drugs as Use Surges

The U.S. Food and Drug Administration has warned that GLP-1 drugs, a fast-growing class of medicines used for diabetes and weight loss, may be linked to a rare eye condition that can cause sudden vision loss. The agency said the risk appears small and the evidence remains mixed, but it wants patients and clinicians to be aware as use of the drugs continues to expand globally.

By RDU Global Wire4 min read

Global Markets & Equities05 Nov 2026, 02:00 PM IST

U.S. Trade Deficit Narrows in September as Exports Rebound, Imports Hit Record High

The U.S. trade deficit narrowed slightly in September 2026 as a pickup in goods exports offset a still-elevated import bill, according to the Bureau of Economic Analysis. The data suggest external trade remained a mixed force for the economy, with stronger outbound shipments helping the balance even as domestic demand continued to support record inbound flows.

5 min readRead →

Big Tech, Cloud & Semiconductors02 Nov 2026, 02:00 PM IST

FDA Moves to Withdraw Tavneos Approval, Exposing a Harder Question: What Happens to Patients Now?

The U.S. Food and Drug Administration is seeking to pull its approval of Tavneos after concluding the drug was cleared on the basis of manipulated study data, a rare and consequential move that could reverberate across drug regulation. The case highlights the tension between policing scientific integrity and preserving patient access to a treatment already on the market.

6 min readRead →

Global Economy & Central Banks16 Oct 2026, 02:38 AM IST

U.S. Weighs ‘Mother of All Bombs’ Option as Iran Vows to Keep Fighting

The U.S. military has reportedly prepared strike options for Iran that include the possible use of one of its largest nonnuclear bombs, escalating fears of a wider confrontation in the Middle East. Tehran has responded with defiance, signaling it will continue to resist pressure even as markets and policymakers brace for further volatility.

5 min readRead →

Global Markets & Equities15 Oct 2026, 11:54 PM IST

FDA Signals Stricter, More Predictable Rare Disease Drug Review Framework

The U.S. Food and Drug Administration’s new leadership is moving to reshape how rare disease therapies are evaluated, with an emphasis on consistency, predictability and a more structured approval pathway. The initiative could materially affect drug developers, investors and patients by narrowing the discretion that has long defined this corner of the regulatory process.

5 min readRead →

Global Markets & Equities15 Oct 2026, 02:39 PM IST

FDA Moves to Tighten Rare-Disease Drug Reviews as New Leadership Seeks Consistency

The U.S. Food and Drug Administration is advancing a new rare-disease framework that could reshape how experimental treatments are designed, reviewed and approved. The initiative signals a shift toward greater consistency and broader evidentiary standards, a move that may raise the bar for developers while potentially improving regulatory predictability.

6 min readRead →

Clean Energy & Climate Transition08 Oct 2026, 01:37 AM IST

Museum Fish Discovery Rewrites a 50-Million-Year Gap in Evolutionary History

A fish specimen overlooked in a museum drawer for roughly 150 years has helped scientists bridge a 50-million-year gap in the evolutionary record, underscoring the continuing scientific value of historical collections. The finding is a reminder that major advances in climate and biodiversity research can emerge not only from new fieldwork, but also from reexamining specimens long thought to be routine.

5 min readRead →

Clean Energy & Climate Transition06 Oct 2026, 11:01 AM IST

Scientists Decode an ‘Undruggable’ Cancer Gene, Opening a New Therapeutic Path

Researchers have made a significant advance in understanding the biology of a long-elusive cancer gene once considered too difficult to target with medicines. The work does not amount to an immediate cure, but it could reshape drug development by revealing vulnerabilities that may be exploited in future therapies.

5 min readRead →

Global Markets & Equities06 Oct 2026, 04:52 AM IST

FDA Says More Than 122,000 Cases of Gatorade Recalled Over Undeclared Food Dyes

The U.S. Food and Drug Administration says more than 122,000 cases of Gatorade have been recalled after undeclared food dyes were found in certain products, raising labeling and compliance concerns for one of the world’s best-known beverage brands. The recall spans 37 states and underscores how even a packaging or formulation disclosure lapse can trigger a broad consumer safety response and reputational risk for a major consumer staples company.

5 min readRead →

Global Markets & Equities06 Oct 2026, 04:30 AM IST

FDA Says More Than 122,000 Cases of Gatorade Recalled Over Undeclared Food Dyes

PepsiCo has recalled more than 122,000 cases of Gatorade after U.S. regulators said certain products contained undeclared food dyes, a labeling issue that can trigger compliance scrutiny and consumer safety concerns. The recall spans more than 30 states and underscores the operational and reputational risks tied to ingredient disclosure in the packaged beverage sector.

5 min readRead →

Global Markets & Equities04 Oct 2026, 05:10 AM IST

Dividend Income Is Still a Retirement Strategy, but the Real Test Is Quality

A fresh wave of market commentary is reviving the case for dividend investing as a retirement-income strategy, with analysts highlighting two high-yield picks that reportedly offer about 8% annual income. The broader message is less about chasing the highest payout and more about building durable cash flow through quality, diversification, and disciplined risk control.

5 min readRead →

Clean Energy & Climate Transition04 Oct 2026, 04:07 AM IST

Poxvirus-Hosted Human Gene Reveals a Rare Case of Viral Genetic Retention

Scientists have identified an unusual poxvirus that appears to have acquired a human gene and retained it in a way not previously seen, offering a striking example of cross-species genetic transfer. The finding deepens understanding of viral evolution and raises new questions about how pathogens adapt, persist, and interact with host biology.

5 min readRead →

Clean Energy & Climate Transition04 Oct 2026, 03:05 AM IST

At Seattle’s Pacific Science Center, the Dinosaurs Are a Test of Climate-Smart Reinvention

The Pacific Science Center’s dinosaur exhibit has become more than a crowd-pleasing attraction: it is now a window into how cultural institutions are adapting to the clean-energy and climate-transition era. As museums confront rising operating costs, decarbonization pressures, and changing public expectations, even a prehistoric display can reveal the economics of modernization. The question is not only what happened to the dinosaurs, but what their fate says about the future of science education in a warming world.

6 min readRead →

Big Tech, Cloud & SemiconductorsJust now (09:08 AM IST)

Two Federal Breaches in One Month Expose a Deepening U.S. Cybersecurity Failure

A pair of cyber intrusions at U.S. federal agencies within the span of a month has exposed a troubling volume of sensitive government data, underscoring persistent weaknesses in public-sector cyber defenses. The incidents, coming amid heightened concern over cloud and supply-chain security, have intensified scrutiny of how federal systems are protected, monitored, and segmented.

6 min readRead →

📍 About this Entity

Countries, administrative states, financial centers, conflict zones and trade straits. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Washington, D.C.:

U.S. Food and Drug Administration(7)Washington, D.C.(6)United States(3)The New York Times(2)Gatorade(2)Department of Health and Human Services(2)